Oncolytics Biotech - 48 Year Dividend Yield History | ONCY

Historical dividend payout and yield for Oncolytics Biotech (ONCY) since 1971. The current TTM dividend payout for Oncolytics Biotech (ONCY) as of February 19, 2019 is $0.00. The current dividend yield for Oncolytics Biotech as of February 19, 2019 is 0.00%.
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $0.035B $0.000B
Oncolytics Biotech, Inc. focuses on the discovery and development of pharmaceutical products for the treatment of a wide variety of human and companion pet cancers. The Company was formed to explore the oncolytic capability of the reovirus, a virus that preferentially replicates in cells with an activated Ras pathway, one of the most common family of genetic defects leading to cancer.
Stock Name Country Market Cap PE Ratio
Amgen (AMGN) United States $116.347B 12.98
Gilead Sciences (GILD) United States $86.362B 10.84
Bio-Techne Corp (TECH) United States $7.246B 48.82